Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $121 and $184, respectively); and amortized cost: $303,191 and $300,555, respectively	$ 277,736	$ 281,412
Equity securities	754	757
Contractholder-directed equity securities and fair value option securities, at estimated fair value	10,106	10,331
Mortgage loans (net of allowance for credit loss of $806 and $721, respectively)	89,802	92,506
Policy loans	8,691	8,788
Real estate and real estate joint ventures (includes $321 and $317, respectively, under the fair value option; $34 and $0, respectively, of real estate held-for-sale; $210 and $0, respectively, relating to variable interest entities)	13,517	13,332
Other limited partnership interests	14,288	14,764
Short-term investments, principally at estimated fair value	3,804	6,045
Other invested assets (includes $1,863 and $1,993, respectively, of leveraged and direct financing leases; $429 and $333, respectively, relating to variable interest entities)	18,131	18,202
Total investments	436,829	446,137
Cash and cash equivalents, principally at estimated fair value	20,786	20,639
Accrued investment income	3,657	3,589
Premiums, reinsurance and other receivables	31,820	28,971
Market risk benefits, at estimated fair value	356	286
Deferred policy acquisition costs and value of business acquired	19,568	20,151
Current income tax recoverable	348	190
Deferred income tax asset	2,681	2,612
Goodwill	8,950	9,236
Other assets	11,043	11,139
Separate account assets	139,707	144,634
Total assets	675,745	687,584
Liabilities
Future policy benefits	190,993	196,406
Policyholder account balances	219,543	219,269
Market risk benefits, at estimated fair value	2,618	3,179
Other policy-related balances	19,379	19,736
Policyholder dividends payable	365	386
Payables for collateral under securities loaned and other transactions	17,719	17,524
Short-term debt (includes $113 and $0, respectively, relating to variable interest entities)	390	119
Long-term debt	14,809	15,548
Collateral financing arrangement	555	637
Junior subordinated debt securities	3,163	3,161
Deferred income tax liability	216	927
Other liabilities	38,748	35,805
Separate account liabilities	139,707	144,634
Total liabilities	648,205	657,331
Contingencies, Commitments and Guarantees (Note 19)
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference	0	0
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,193,636,489 and 1,191,823,651 shares issued, respectively; 703,760,956 and 730,821,111 shares outstanding, respectively	12	12
Additional paid-in capital	33,740	33,690
Retained earnings	40,873	40,146
Treasury stock, at cost; 489,875,533 and 461,002,540 shares, respectively	(26,637)	(24,591)
Accumulated other comprehensive income (loss)	(20,736)	(19,242)
Total MetLife, Inc.’s stockholders’ equity	27,252	30,015
Noncontrolling interests	288	238
Total equity	27,540	30,253
Total liabilities and equity	$ 675,745	$ 687,584